Stunting is a nutritional problem that affects only in terms of health but affects intelligence One strategy to overcome stunting is nutrition in pregnant women to increase knowledge in the First 1000 Days of Life by providing education for pregnant women. The purpose of this research was to develop educational media products in the form of modules to support the risk of stunting intended for pregnant women. Research development at the Borg & Gell development research stage. The initial stage begins with a FGD and a preliminary study, then a module feasibility test and a small sample user trial are carried out, followed by a study using a Quasi Experiment (pre-test post-test design). 30 pregnant women domiciled in the working area of the Cangadi Community Health Center were sampled with a purposive sampling technique. The results showed that respondents gained 82.5% increased knowledge. This agreed that the module developed could increase the knowledge of pregnant women. Keywords: Stunting, Development Module, Stunting Risk Detection, knowledge of pregnant women. ABSTRAK Stunting merupakan masalah gizi kronis yang berdampak tidak hanya pada segi kesehatan tapi mempengaruhi kecerdasan Salah satu strategi untuk mengatasi stunting yakni intervensi gizi pada ibu hamil untuk meningkatkan pengetahuan pada 1000 Hari Pertama Kehidupan dengan pemberian edukasi kepada ibu hamil. Penelitian ini bertujuan menghasilkan produk media edukasi berbentuk modul untuk mendeteksi risiko stunting yang diperuntukkan bagi ibu hamil. Penelitain pengembangan mengacu pada tahapan penelitian pengembangan Borg & Gell. Tahap awal diawali dengan FGD dan studi pendahuluan, selanjutnya dilakukan uji kelayakan modul dan uji coba pengguna sampel kecil, lalu dilanjutkan dengan penelitian yang menggunakan Quasi Eksperimen (Pre–test post–test design). 30 orang ibu hamil yang berdomisili di wilayah kerja Puskesmas Cangadi dijadikan sampel dengan teknik purposive sampling. Hasil penelitian menunjukkan bahwa mayoritas responden yakni 82.5% mengalami peningkatan pengetahuan hal ini menyatakan bahwa modul yang dikembangkan dapat meningkatkan pengetahuan ibu hamil. Kata kunci: Stunting, Pengembangan Modul, Deteksi Risiko stunting, pengetahuan ibu hamil.
Objective To determine if treatment with pravastatin prevents preeclampsia in pregnant patients at risk for preeclampsia. Material & Methods The study was performed in four major tertiary hospitals in Surabaya, Bandung, and Makassar between 2017-2021. Pregnant women at high risk of developing preeclampsia were recruited and randomized into an intervention group and control group. The control group received low dose aspirin (80 mg) and calcium (1 g) daily, while the intervention group received additional pravastatin (20 mg twice daily) started from 14-20 weeks’ gestation until delivery. The pregnancy was followed until delivery, and the clinical data was collected. The primary outcome was the occurrence of preeclampsia. Result A total of 173 people participated in this study, including 86 in the control group and 87 in the pravastatin group. The pravastatin group had a significantly lower rate of preterm preeclampsia (13.8% vs 26.7%; p=0.034; (OR=0.034, 95% CI: 0.202-0.905) and preterm birth (16.1 % vs. 36 %; p=0.003; OR= 0.340, 95% CI: 0.165-0.7), mostly indicated preterm birth. Preeclampsia occurs later in the pravastatin group than in the control group (36.39+2.32 vs 34.89+3.38 weeks, p=0.048). Overall the pravastatin group had better perinatal outcomes. Neonates with low Apgar scores (<7) at 1 minute (5.7% vs 25.6%, p=0.000) and 5 minutes (2.3% vs 25.6%, p=0.028) were significantly less common in the pravastatin group. Additionally, the rate of low birthweight babies (< 2500g) was lower in pravastatin group (27.6% vs 40.7%; p= 0.069). Conclusion Pravastatin (20 mg bid) significantly reduces the risk for preterm preeclampsia and preterm birth in women at a high risk of developing preeclampsia.
Objektif: Aromaterapi lavender suatu metode atau cara aman yang dapat digunakan bagi ibu hamil dalam meminimalisir tingkat kecemasan atau stres. Aromaterapi lavender memiliki banyak manfaat salah satunya untuk relaksasi dan memiliki kandungan aktif utama yaitu linalool dan linalyl acetate yang memiliki efek An-Anxiety (anti-cemas). Metode: Jenis penelitian deskriptif kuantitatif desain quasy experimental dengan pendekatan one group prepost test design. Dilaksanakan di wilayah kerja Puskesmas Tolo’ Kabupaten Je’neponto pada bulan Mei hingga Juni 2021. Sampel dalam penelitian ini adalah 25 orang ibu hamil. Kriteria dalam penelitian ini adalah ibu hamil normal trimester II dan bersedia menjadi responden. Hasil: Terdapat pengaruh pemberian aromaterapi lavender terhadap perubahan tekanan darah sistol,diastol dan nadi pada ibu hamil pada hari ke 1-7 dengan nilai P-value <0,05 tekanan darah sistol(p=0,00), diastol (p=0,00) dan nadi (p=0,04). Sedangkan tidak terdapat pengaruh pemberian aromaterapi lavender terhadap kadar kortisol pada ibu hamil (p=0,63, p<0,05). Tidak terdapat perbedaan secara signifikan efek aromaterapi lavender terhadap kadar kortisol pada ibu hamil nilai p-value 0,06. Berbeda dengan tekanan darah sistol dan diastol, terdapat perbedaan secara signifikan efek aromaterapi lavender terhadap perubahan tekanan darah sistol dan diastol pada ibu hamil dengan nilai p-value <0,05 yaitu sistol (p=0,00) dan diastol (p=0,01). Kesimpulan: Tidak terdapat perbedaan efek aromaterapi lavender terhadap kadar kortisol pada ibu hamil. Meskipun tidak terdapat perbedaan signifikan tetapi terdapat penurunan kadar pada ibu hamil. Sedangkan untuk tekanan darah sistol dan diastol terdapat perbedaan signifikan efek aromaterapi lavender terhadap tekanan darah sistol dan diastol pada ibu hamil
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.